In particular, variant 2/4 is considered a specific biomarker for SSc because the ratio of variant 2/4 to total periostin in SSc skin fibroblasts is higher than in control fibroblasts in the presence of TGF-β. Here, TGFB1 is linked to systemic sclerosis.